SCHEMBL22987944

SCHEMBL22987944

NNC(=O)c1ccccc1OC(F)(F)C(F)F

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.57
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
KCNK3 O14649 4/20 0.44
KCNK9 Q9NPC2 4/20 0.44
ALDH1A1 P00352 4/20 0.44
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
F2R P25116 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
HCRTR1 O43613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29646310 1.00 CTSD (0.57) CTSDMEN1KMT2AKCNK3KCNK9
SCHEMBL376957 0.85 CTSD (0.62) CTSDMEN1KMT2AKCNK3KCNK9
SCHEMBL29646406 0.85 CTSD (0.62) CTSDMEN1KMT2AKCNK3KCNK9
Hydrochloric Acid SCHEMBL5800475 0.84 CTSD (0.60) CTSDMEN1KMT2AKCNK3KCNK9
SCHEMBL2366561 0.82 ALDH1A1 (0.44) MEN1KMT2AKCNK3KCNK9ALDH1A1
SCHEMBL3548983 0.82 IRAK4 (0.53) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL976982 0.80 KDM4E (0.50) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL3665352 0.79 TSHR (0.40) MEN1KMT2AKCNK3KCNK9ALDH1A1
SCHEMBL22987538 0.79 CTSD (0.62) CTSDMEN1KMT2AALDH1A1MAPT
SCHEMBL29646356 0.79 CTSD (0.62) CTSDMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-13 US disclosed
CN-114466850-A [1,2,4] triazolo [1,5-C ] quinazolin-5-amines 拜耳股份有限公司 2022-05-10 CN disclosed
WO-2021028382-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES BAYER AKTIENGESELLSCHAFT (DE) 2021-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230113037-A1 [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES AHR, HRH4, HRH1 CTSD 3441/4885MEN1 1941/4885KMT2A 919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.